180 Life Sciences

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ATNF and other ETFs, options, and stocks.

About ATNF

180 Life Sciences Corp. operates as a clinical-stage biotechnology company, which engages in the development of novel drugs that fulfill unmet needs in inflammatory diseases, fibrosis and pain by leveraging the combined expertise of luminaries in therapeutics from Oxford University, the Hebrew University and Stanford University. The company was founded by Marc Feldmann, Lawrence J. 

CEO
Blair Jordan
CEOBlair Jordan
Employees
3
Employees3
Headquarters
Palo Alto, California
HeadquartersPalo Alto, California
Founded
2016
Founded2016
Employees
3
Employees3

ATNF Key Statistics

Market cap
6.61M
Market cap6.61M
Price-Earnings ratio
-0.18
Price-Earnings ratio-0.18
Dividend yield
Dividend yield
Average volume
124.05K
Average volume124.05K
High today
$1.17
High today$1.17
Low today
$1.08
Low today$1.08
Open price
$1.11
Open price$1.11
Volume
10.19K
Volume10.19K
52 Week high
$17.75
52 Week high$17.75
52 Week low
$0.6578
52 Week low$0.6578

People also own

Based on the portfolios of people who own ATNF. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.